Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa

NCT00100230 is registered in ClinicalTrials.gov with Retina Foundation of the Southwest as lead sponsor.

NCT NCT00100230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Effectiveness and Safety of High Dose Docosahexaenoic Acid (DHA) in X-Linked Retinitis Pigmentosa
Lead sponsor
Retina Foundation of the Southwest
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
August 31, 2014
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinitis pigmentosa, x-linked genetic diseases